Healthcare provider profile · identity verified

Ruby Ann Rivera, ARNP

Nurse Practitioner · WEST SPRINGFIELD, MA · NPI 1962656116

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	215	27
Furosemide	Furosemide	194	29
Amlodipine Besylate	Amlodipine Besylate	154	16
Lisinopril	Lisinopril	139	16
Trazodone Hcl	Trazodone Hcl	133	19
Metoprolol Succinate	Metoprolol Succinate	129	15
Atorvastatin Calcium	Atorvastatin Calcium	123	17
Duloxetine Hcl	Duloxetine Hcl	119	12
Pantoprazole Sodium	Pantoprazole Sodium	111	22
Tamsulosin Hcl	Tamsulosin Hcl	109	18
Eliquis	Apixaban	98	16
Potassium Chloride	Potassium Chloride	89	14
Metoprolol Tartrate	Metoprolol Tartrate	80	11
Sertraline Hcl	Sertraline Hcl	78	11
Tramadol Hcl	Tramadol Hcl	76	26
Omeprazole	Omeprazole	75	suppressed
Famotidine	Famotidine	73	11
Fluoxetine Hcl	Fluoxetine Hcl	70	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	69	27
Levothyroxine Sodium	Levothyroxine Sodium	67	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	66	suppressed
Oxycodone Hcl	Oxycodone Hcl	66	17
Montelukast Sodium	Montelukast Sodium	63	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	63	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	59	suppressed
Clonazepam	Clonazepam	56	suppressed
Losartan Potassium	Losartan Potassium	54	suppressed
Spironolactone	Spironolactone	53	suppressed
Mirtazapine	Mirtazapine	52	suppressed
Metformin Hcl	Metformin Hcl	51	suppressed
Finasteride	Finasteride	48	suppressed
Trulicity	Dulaglutide	46	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	suppressed
Lorazepam	Lorazepam	43	13
Dapagliflozin	Dapagliflozin Propanediol	42	suppressed
Fluticasone Propionate	Fluticasone Propionate	41	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	39	suppressed
Carvedilol	Carvedilol	38	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Buspirone Hcl	Buspirone Hcl	37	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	37	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	37	suppressed
Tizanidine Hcl	Tizanidine Hcl	37	12
Pregabalin	Pregabalin	36	suppressed
Meclizine Hcl	Meclizine Hcl	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	32	suppressed
Azelastine Hcl	Azelastine Hcl	31	suppressed
Solifenacin Succinate	Solifenacin Succinate	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Baclofen	Baclofen	29	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Meloxicam	Meloxicam	28	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	28	suppressed
Januvia	Sitagliptin Phosphate	27	suppressed
Allopurinol	Allopurinol	26	suppressed
Prednisone	Prednisone	26	18
Calcitriol	Calcitriol	25	suppressed
Gemtesa	Vibegron	25	suppressed
Cefpodoxime Proxetil	Cefpodoxime Proxetil	24	19
Fluticasone-Vilanterol	Fluticasone/Vilanterol	24	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Glipizide	Glipizide	22	suppressed
Oxcarbazepine	Oxcarbazepine	22	suppressed
Alprazolam	Alprazolam	21	suppressed
Atenolol	Atenolol	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Olanzapine	Olanzapine	21	suppressed
Ozempic	Semaglutide	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Wegovy	Semaglutide	21	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Rexulti	Brexpiprazole	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Cefuroxime	Cefuroxime Axetil	19	16
Ezetimibe	Ezetimibe	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Torsemide	Torsemide	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Celecoxib	Celecoxib	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	13
Ondansetron Odt	Ondansetron	17	suppressed
Azithromycin	Azithromycin	16	suppressed
Clopidogrel	Clopidogrel Bisulfate	16	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	16	suppressed
Lactulose	Lactulose	16	suppressed
Nuedexta	Dextromethorphan Hbr/Quinidine	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Metolazone	Metolazone	15	suppressed
Mirabegron Er	Mirabegron	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Alendronate Sodium	Alendronate Sodium	14	suppressed
Alogliptin	Alogliptin Benzoate	14	suppressed
Bupropion Hcl	Bupropion Hcl	14	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Kapspargo Sprinkle	Metoprolol Succinate	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Latanoprost	Latanoprost	14	suppressed
Mesalamine Dr	Mesalamine	14	suppressed
Moexipril Hcl	Moexipril Hcl	14	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Belsomra	Suvorexant	13	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	13	suppressed
Labetalol Hcl	Labetalol Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Soaanz	Torsemide	13	suppressed
Topiramate Er	Topiramate	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Lidocaine	Lidocaine	12	suppressed
Primidone	Primidone	12	suppressed
Cephalexin	Cephalexin	11	11
Diltiazem 24hr Er (La)	Diltiazem Hcl	11	suppressed
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Lacosamide	Lacosamide	11	suppressed
Lurasidone Hcl	Lurasidone Hcl	11	suppressed
Mycophenolic Acid	Mycophenolate Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error